Oh I don't know.
Methiopropamine has been good in my experience of it, doesn't seem particularly prone to comedowns of a horrific nature (albeit, I have never used more than 1.2g-1.5g AT MOST, over a couple of days. (vaped or via IV) and never had a comedown to speak of.
For simple stimulants, the cathinones don't look too bad on paper, in fact, IMO often they look better than the amphetamines, when it comes to Ki values at SERT/DAT/NET, favouring DA reuptake inhibition/release over NE. Psychedelic (I,e 5HT2a agonist) cathinones other than MDO are problematic of course due to the dimerization issues already known.
But there with the phenethylamine psychedelics a primary amine seems essential, further alkylation at N killing off most of the activity. I'd be rather curious to bioassay primary amine psychedelic cathinone candidates in the form of the pthalimidopropiophenole pro-drugs, N-alkylation does not, of course, present this issue with the simplistic amphetamine type stimlants, like meth/ethcathinone, and I see little reason why changing the heterocycle from phenyl to thienyl should make the compounds any more unstable than they are already. And personally, I far prefer DARIs to release agents.